Elisavet Paplomata, MD

Dr. Paplomata received her medical degree from the Cerrahpasa Faculty of Medicine, University of Istanbul, in Turkey. She trained in Obstetrics and Gynecology from 2005 to 2008 at the General Hospital of Serres in Greece, where she gained experience in cancer screening and the surgical management of benign and malignant gynecologic conditions. She then completed her residency in Internal Medicine at Texas Health Presbyterian of Dallas in Texas. She completed her fellowship in Hematology and Medical Oncology at Emory University School of Medicine while holding the position of Chief Fellow in her last year.

Dr. Paplomata's research focus is in mechanisms of resistance in breast cancer. She has participated in basic science research and translational research on mechanisms of resistance to HER2-directed therapies and chemotherapy. She is currently an investigator or co-investigator in multiple trials taking place at Winship Cancer Institute.

Dr. Paplomata's recent awards include:

• Outstanding Resident of the Year Award, Presbyterian Hospital of Dallas, 2011
• 3rd Place Poster Competition: “Treatment of IgG4-Related Fibrosing Mediastinitis with Tamoxifen and Prednisone,” presented at the Texas Chapter of ACP, 2011